Adenosine dysfunction in astrogliosis: cause for seizure generation?

被引:83
作者
Li, Tianfu [1 ]
Lan, Jing Quan [1 ]
Fredholm, Bertil B. [2 ]
Simon, Roger P. [1 ]
Boison, Detlev [1 ]
机构
[1] RS Dow Neurobiol Labs, Portland, OR 97232 USA
[2] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
关键词
epileptogenesis; kainic acid; status epilepticus; A(1) receptor; astrocyte;
D O I
10.1017/S1740925X0800015X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Epilepsy is characterized by both ilcuronal and astroglial dysfunction. The endogenous anticonvulsont adcnosine, the level of which is largely controlled by astrocytes, might provide a crucial link between astrocyte and neuron dysfunction in epilepsy. Here we have studied astrogliosis, a hallmark of the epileptic brain, adenosine dysfunction and the emergence of spontaneous seizures in a cornprchc"sivc approach that includes a new mouse model offocal epileptogenesis, mutant mice with altered brain levels of adenosille, and mice lacking adenosine A, receptors. In wild-typc mice, following a focal epileptogetiesisprecipitating injury, astrogliosis, upregulation of the adenosine-removing astrocytic enzyme adenosille killase (ADK), and spontaneous seizures coincide in a spatio-temporally restricted manner. Importantly, these spontaneous seizures tire mimicked by untreated transgcnic micc that either overexpress ADK in brain at- lack A, receptors. Conversely, mice with reduced ADK in the forebrain do not develop either astrogliosis or spontaneous seizures. Our studies define ADK as a crucial upstream regulator of A, rcceptor-mediated modulation of neuronal excitability, and support the ADK hypothesis of epileptogenesis in which uprcgulation of ADK during astrogliosis provides a crucial link between astrocyte and neuron dysfunction in epilepsy. These findings define ADK as rational target for therapeutic intervention.
引用
收藏
页码:353 / 366
页数:14
相关论文
共 67 条
[1]   UP-REGULATION OF A1 ADENOSINE RECEPTORS IN HUMAN TEMPORAL-LOBE EPILEPSY - A QUANTITATIVE AUTORADIOGRAPHIC STUDY [J].
ANGELATOU, F ;
PAGONOPOULOU, O ;
MARAZIOTIS, T ;
OLIVIER, A ;
VILLEMEURE, JG ;
AVOLI, M ;
KOSTOPOULOS, G .
NEUROSCIENCE LETTERS, 1993, 163 (01) :11-14
[2]   ACTIVITIES AND SOME PROPERTIES OF 5'-NUCLEOTIDASE, ADENOSINE KINASE AND ADENOSINE-DEAMINASE IN TISSUES FROM VERTEBRATES AND INVERTEBRATES IN RELATION TO CONTROL OF CONCENTRATION AND PHYSIOLOGICAL-ROLE OF ADENOSINE [J].
ARCH, JRS ;
NEWSHOLME, EA .
BIOCHEMICAL JOURNAL, 1978, 174 (03) :965-977
[3]   The equilibrative nucleoside transporter family, SLC29 [J].
Baldwin, SA ;
Beal, PR ;
Yao, SYM ;
King, AE ;
Cass, CE ;
Young, JD .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2004, 447 (05) :735-743
[4]   Neonatal hepatic steatosis by disruption of the adenosine kinase gene [J].
Boison, D ;
Scheurer, L ;
Zumsteg, V ;
Rülicke, T ;
Litynski, P ;
Fowler, B ;
Brandner, S ;
Mohler, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (10) :6985-6990
[5]   The adenosine kinase hypothesis of epileptogenesis [J].
Boison, Deflev .
PROGRESS IN NEUROBIOLOGY, 2008, 84 (03) :249-262
[6]   Adenosine as a neuromodulator in neurological diseases [J].
Boison, Detlev .
CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (01) :2-7
[7]   Adenosine as a modulator of brain activity [J].
Boison, Detlev .
DRUG NEWS & PERSPECTIVES, 2007, 20 (10) :607-611
[8]   Adenosine-based cell therapy approaches for pharmacoresistant epilepsies [J].
Boison, Detlev .
NEURODEGENERATIVE DISEASES, 2007, 4 (01) :28-33
[9]   Cell and gene therapies for refractory epilepsy [J].
Boison, Detlev .
CURRENT NEUROPHARMACOLOGY, 2007, 5 (02) :115-125
[10]   Adenosine kinase, epilepsy and stroke: mechanisms and therapies [J].
Boison, Detlev .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (12) :652-658